{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:53:23Z","timestamp":1792194803500,"version":"4.4.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Combined antiretroviral therapy (cART) can inhibit the replication of human immunodeficiency virus type 1 (HIV-1) and reduce viral loads in the peripheral blood to undetectable levels. However, the presence of latent HIV-1 reservoirs prevents complete HIV-1 eradication. Several drugs and strategies targeting T cells are now in clinical trials, but their effectiveness in reducing viral reservoirs has been mixed. Interestingly, innate immune natural killer (NK) cells, which are promising targets for cancer therapy, also play an important role in HIV-1 infection. NK cells are a unique innate cell population with features of adaptive immunity that can regulate adaptive and innate immune cell populations; therefore, they can be exploited for HIV-1 immunotherapy and reservoir eradication. In this review, we highlight immunotherapy strategies for HIV infection that utilize the beneficial properties of NK cells.<\/jats:p>","DOI":"10.3389\/fimmu.2022.842746","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T02:18:54Z","timestamp":1647397134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance"],"prefix":"10.3389","volume":"13","author":[{"given":"Siqin","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12916-015-0517-y","article-title":"HIV-1 Functional Cure: Will the Dream Come True","volume":"13","author":"Liu","year":"2015","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.62.081307.162758","article-title":"Cell Biology of HIV-1 Infection of Macrophages","volume":"62","author":"Carter","year":"2008","journal-title":"Annu Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0166-3542(02)00052-9","article-title":"Macrophages and HIV Infection: Therapeutical Approaches Toward This Strategic Virus Reservoir","volume":"55","author":"Aquaro","year":"2002","journal-title":"Antiviral Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1972","article-title":"Avoiding the Void: Cell-to-Cell Spread of Human Viruses","volume":"6","author":"Sattentau","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-7-199604010-00006","article-title":"Immunopathogenic Mechanisms of HIV Infection","volume":"124","author":"Fauci","year":"1996","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/cancers12082131","article-title":"Natural Born Killers: NK Cells in Cancer Therapy","volume":"12","author":"Franks","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK Cell Platform for Cancer Immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK Cell-Based Cancer Immunotherapy: From Basic Biology to Clinical Development","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00877-6","article-title":"The Role of Natural Killer Cells in Liver Inflammation","volume":"43","author":"Highton","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and Clinical Relevance of Human Natural Killer Cells","volume":"76","author":"Robertson","year":"1990","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90175-2","article-title":"Human T, B, Natural Killer, and Dendritic Cells Arise From a Common Bone Marrow Progenitor Cell Subset","volume":"3","author":"Galy","year":"1995","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2594.2594","article-title":"Differentiation of Natural Killer (NK) Cells From Human Primitive Marrow Progenitors in a Stroma-Based Long-Term Culture System: Identification of a CD34+7+ NK Progenitor","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1179","article-title":"IL-15 is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation","volume":"167","author":"Mattei","year":"2001","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01176","article-title":"NKG2C(+)NKG2A(-) Natural Killer Cells are Associated With a Lower Viral Set Point and may Predict Disease Progression in Individuals With Primary HIV Infection","volume":"8","author":"Ma","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/lt.22080","article-title":"Liver Grafts Contain a Unique Subset of Natural Killer Cells That are Transferred Into the Recipient After Liver Transplantation","volume":"16","author":"Moroso","year":"2010","journal-title":"Liver Transpl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","article-title":"Human Liver-Resident CD56(bright)\/CD16(neg) NK Cells are Retained Within Hepatic Sinusoids via the Engagement of CCR5 and CXCR6 Pathways","volume":"66","author":"Hudspeth","year":"2016","journal-title":"J Autoimmun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","article-title":"Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry","volume":"5","author":"Horowitz","year":"2013","journal-title":"Sci Transl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","article-title":"Functions of Natural Killer Cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181454","article-title":"NK Cells Switch From Granzyme B to Death Receptor-Mediated Cytotoxicity During Serial Killing","volume":"216","author":"Prager","year":"2019","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by Antibodies: Recent Progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-Killer Cells and Dendritic Cells: \"L'union Fait La Force\"","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coviro.2015.10.008","article-title":"Roles of Natural Killer Cells in Antiviral Immunity","volume":"16","author":"Waggoner","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue Determinants of Human NK Cell Development, Function, and Residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1086\/513878","article-title":"Evolution of Innate and Adaptive Effector Cell Functions During Acute HIV-1 Infection","volume":"195","author":"Alter","year":"2007","journal-title":"J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2336091100","article-title":"Natural Killer Cells in HIV-1 Infection: Dichotomous Effects of Viremia on Inhibitory and Activating Receptors and Their Functional Correlates","volume":"100","author":"Mavilio","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nri1711","article-title":"NK Cells in HIV Infection: Paradigm for Protection or Targets for Ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0410225","article-title":"Pathologic Natural Killer Cell Subset Redistribution in HIV-1 Infection: New Insights in Pathophysiology and Clinical Outcomes","volume":"88","author":"Brunetta","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001645","article-title":"Natural Killer Cells in HIV-1 Infection and Therapy","volume":"31","author":"Mikulak","year":"2017","journal-title":"Aids"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1023\/a:1015476114409","article-title":"Selective Depletion of CD56(dim) NK Cell Subsets and Maintenance of CD56(bright) NK Cells in Treatment-Naive HIV-1-Seropositive Individuals","volume":"22","author":"Tarazona","year":"2002","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1997.d01-98.x","article-title":"Clinical Progression of HIV Infection: Role of NK Cells","volume":"46","author":"Bruunsgaard","year":"1997","journal-title":"Scand J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.5663","article-title":"Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed But Uninfected Vietnamese Intravascular Drug Users","volume":"171","author":"Scott-Algara","year":"2003","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.02.008","article-title":"Increased IFN-Gamma Production by NK and CD3+\/CD56+ Cells in Sexually HIV-1-Exposed But Uninfected Individuals","volume":"120","author":"Montoya","year":"2006","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/jci2323","article-title":"Natural Killer Cells From Human Immunodeficiency Virus (HIV)-Infected Individuals are an Important Source of CC-Chemokines and Suppress HIV-1 Entry and Replication In Vitro","volume":"102","author":"Oliva","year":"1998","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2018.08.064","article-title":"RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated With Induction of HIV Broadly Neutralizing Antibody Responses","volume":"175","author":"Bradley","year":"2018","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies","volume":"9","author":"Fl\u00f3rez-\u00c1lvarez","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/487439a","article-title":"HIV: Shock and Kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00356","article-title":"HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function","volume":"7","author":"Garrido","year":"2016","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01484-15","article-title":"Innate Immune Activity Correlates With CD4 T Cell-Associated HIV-1 DNA Decline During Latency-Reversing Treatment With Panobinostat","volume":"89","author":"Olesen","year":"2015","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1111","article-title":"Pegylated Interferon-\u03b1-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1\/Hepatitis C Virus-Coinfected Patients","volume":"66","author":"Hua","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801511","article-title":"NK Response Correlates With HIV Decrease in Pegylated IFN-\u03b12a-Treated Antiretroviral Therapy-Suppressed Subjects","volume":"203","author":"Papasavvas","year":"2019","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.4.1648-1657.2000","article-title":"Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells From Rhesus Macaques During Acute Infection With Pathogenic Simian Immunodeficiency Virus","volume":"74","author":"Giavedoni","year":"2000","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830050209","article-title":"\u201cNatural\u201d Killer Cells in the Mouse. II. Cytotoxic Cells With Specificity for Mouse Moloney Leukemia Cells. Characteristics of the Killer Cell","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200206140-00007","article-title":"Normalization of Natural Killer Cell Function and Phenotype With Effective Anti-HIV Therapy and the Role of IL-10","volume":"16","author":"Parato","year":"2002","journal-title":"Aids"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060894","article-title":"Characterization of the Defective Interaction Between a Subset of Natural Killer Cells and Dendritic Cells in HIV-1 Infection","volume":"203","author":"Mavilio","year":"2006","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00909","article-title":"The Natural Cytotoxicity Receptors in Health and Disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK Cells for Cancer Immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1006\/smim.2000.0213","article-title":"NK Cell Recognition of Non-Classical HLA Class I Molecules","volume":"12","author":"L\u00f3pez-Botet","year":"2000","journal-title":"Semin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2008.0081","article-title":"Changes in NK Cell Counts and Receptor Expressions and Emergence of CD3(dim)\/CD56+ Cells in HIV-1 Infected Patients in China","volume":"22","author":"Fu","year":"2009","journal-title":"Viral Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792775","article-title":"Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.798235","article-title":"A Genome-Wide CRISPR\/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors","volume":"12","author":"Klein","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/00029330-200709010-00015","article-title":"Distribution of Natural Killer Cell Receptors in HIV Infected Individuals","volume":"120","author":"Jiang","year":"2007","journal-title":"Chin Med J (Engl)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1086\/382090","article-title":"Expression of Chemokine and Inhibitory Receptors on Natural Killer Cells: Effect of Immune Activation and HIV Viremia","volume":"189","author":"Kottilil","year":"2004","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324141","article-title":"The Impaired NK Cell Cytolytic Function in Viremic HIV-1 Infection is Associated With a Reduced Surface Expression of Natural Cytotoxicity Receptors (NKp46, NKp30 and Nkp44)","volume":"33","author":"De Maria","year":"2003","journal-title":"Eur J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600019","article-title":"Unravelling Natural Killer Cell Function: Triggering and Inhibitory Human NK Receptors","volume":"23","author":"Moretta","year":"2004","journal-title":"EMBO J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK Cells in HIV-1 Infection: Evidence for Their Role in the Control of HIV-1 Infection","volume":"265","author":"Alter","year":"2009","journal-title":"J Intern Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071548198","article-title":"Control of HIV-1 Viremia and Protection From AIDS are Associated With HLA-Bw4 Homozygosity","volume":"98","author":"Flores-Villanueva","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ng934","article-title":"Epistatic Interaction Between KIR3DS1 and HLA-B Delays the Progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00647-17","article-title":"Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro With NKp46\/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells","volume":"91","author":"Marras","year":"2017","journal-title":"J Virol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.04.015","article-title":"NK-DC Interaction: On the Usefulness of Auto-Aggression","volume":"4","author":"Marcenaro","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2016.11.003","article-title":"NK Cells in Host Responses to Viral Infections","volume":"44","author":"Lam","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humimm.2021.09.004","article-title":"Exhausted NK Cells and Cytokine Storms in COVID-19: Whether NK Cell Therapy Could be a Therapeutic Choice","volume":"83","author":"Ghasemzadeh","year":"2022","journal-title":"Hum Immunol"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.137.9.2735","article-title":"Natural Killer Cells: Definition of a Cell Type Rather Than a Function","volume":"137","author":"Lanier","year":"1986","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835861b0","article-title":"Impact of Protective Killer Inhibitory Receptor\/Human Leukocyte Antigen Genotypes on Natural Killer Cell and T-Cell Function in HIV-1-Infected Controllers","volume":"26","author":"Tomescu","year":"2012","journal-title":"Aids"},{"key":"B67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aam8825","article-title":"Elevated HLA-A Expression Impairs HIV Control Through Inhibition of NKG2A-Expressing Cells","volume":"359","author":"Ramsuran","year":"2018","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.04.005","article-title":"HIV-1 Vpu Mediates HLA-C Downregulation","volume":"19","author":"Apps","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005421","article-title":"A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-Cells Highly Susceptible to Attack by NKG2A\/CD94-Bearing Natural Killer Cells","volume":"12","author":"Davis","year":"2016","journal-title":"PLoS Pathog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1226720","article-title":"Therapeutic CD94\/NKG2A Blockade Improves Natural Killer Cell Dysfunction in Chronic Lymphocytic Leukemia","volume":"5","author":"McWilliams","year":"2016","journal-title":"Oncoimmunology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.135301","article-title":"Effects of Anti-NKG2A Antibody Administration on Leukemia and Normal Hematopoietic Cells","volume":"101","author":"Ruggeri","year":"2016","journal-title":"Haematologica"},{"key":"B72","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00395","article-title":"Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection","volume":"10","author":"Alrubayyi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000002596","article-title":"HIV-1 Induced Changes in HLA-C*03\u200a: \u200a04-Presented Peptide Repertoires Lead to Reduced Engagement of Inhibitory Natural Killer Cell Receptors","volume":"34","author":"Ziegler","year":"2020","journal-title":"Aids"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1086\/338828","article-title":"Antibody-Dependent Cell-Mediated Cytotoxicity in Cervical Lavage Fluids of Human Immunodeficiency Virus Type 1\u2013Infected Women","volume":"185","author":"Battle-Miller","year":"2002","journal-title":"J Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1086\/425582","article-title":"Women With Cervicovaginal Antibody-Dependent Cell-Mediated Cytotoxicity Have Lower Genital HIV-1 RNA Loads","volume":"190","author":"Nag","year":"2004","journal-title":"J Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12016","article-title":"Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated With Slow Progression of HIV Infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12879-019-4674-z","article-title":"Fc\u03b3riiia Receptor Polymorphism Influences NK Cell Mediated ADCC Activity Against HIV","volume":"19","author":"Talathi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-Infected Cells by Broadly Neutralizing Antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nature13612","article-title":"Enhanced Neonatal Fc Receptor Function Improves Protection Against Primate SHIV Infection","volume":"514","author":"Ko","year":"2014","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced Clearance of HIV-1-Infected Cells by Broadly Neutralizing Antibodies Against HIV-1 In Vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 Therapy With Monoclonal Antibody 3BNC117 Elicits Host Immune Responses Against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010320117","article-title":"Nanoparticles Presenting Clusters of CD4 Expose a Universal Vulnerability of HIV-1 by Mimicking Target Cells","volume":"117","author":"Hoffmann","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.intimp.2017.08.016","article-title":"Focus on the Therapeutic Efficacy of 3BNC117 Against HIV-1: In Vitro Studies, In Vivo Studies, Clinical Trials and Challenges","volume":"52","author":"Liu","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1198455","article-title":"TriKEs and BiKEs Join CARs on the Cancer Immunotherapy Highway","volume":"12","author":"Tay","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1038\/s41598-017-07966-3","article-title":"One-Domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01850","article-title":"A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease","volume":"10","author":"Lucar","year":"2019","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","article-title":"CD276 Expression Enables Squamous Cell Carcinoma Stem Cells to Evade Immune Surveillance","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00167","article-title":"NK Cell-Based Immune Checkpoint Inhibition","volume":"11","author":"Khan","year":"2020","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5490","article-title":"NK Cell Exhaustion: Bad News for Chronic Disease","volume":"6","author":"Schafer","year":"2015","journal-title":"Oncotarget"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.2053","article-title":"Modulation of Expression of the MHC Class I-Binding Natural Killer Cell Receptors, and NK Activity in Relation to Viral Load in HIV-Infected\/AIDS Patients","volume":"65","author":"Ahmad","year":"2001","journal-title":"J Med Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00660-15","article-title":"Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated With In Situ Differentiation and Functional Anergy","volume":"89","author":"Schafer","year":"2015","journal-title":"J Virol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2011.0096","article-title":"PD-1 Expression on Natural Killer Cells and CD8(+) T Cells During Chronic HIV-1 Infection","volume":"25","author":"Norris","year":"2012","journal-title":"Viral Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12977-015-0142-z","article-title":"Elevated Expression of LAG-3, But Not PD-1, Is Associated With Impaired iNKT Cytokine Production During Chronic HIV-1 Infection and Treatment","volume":"12","author":"Juno","year":"2015","journal-title":"Retrovirology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701551","article-title":"Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells","volume":"201","author":"Porichis","year":"2018","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02450","article-title":"Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists","volume":"10","author":"Macedo","year":"2019","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen Recognition and Innate Immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cell.2020.03.005","article-title":"Curing HIV: Seeking to Target and Clear Persistent Infection","volume":"181","author":"Margolis","year":"2020","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2013.99","article-title":"TLR-Mediated Activation of NK Cells and Their Role in Bacterial\/Viral Immune Responses in Mammals","volume":"92","author":"Adib-Conquy","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2006.08.004","article-title":"The Direct Effects of Toll-Like Receptor Ligands on Human NK Cell Cytokine Production and Cytotoxicity","volume":"241","author":"Lauzon","year":"2006","journal-title":"Cell Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2045860","article-title":"Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy","volume":"2020","author":"Noh","year":"2020","journal-title":"J Immunol Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s40425-019-0796-5","article-title":"A New Synthetic Toll-Like Receptor 1\/2 Ligand Is an Efficient Adjuvant for Peptide Vaccination in a Human Volunteer","volume":"7","author":"Rammensee","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500709","article-title":"TLR-Stimulated Neutrophils Instruct NK Cells To Trigger Dendritic Cell Maturation and Promote Adaptive T Cell Responses","volume":"195","author":"Riise","year":"2015","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1227902","article-title":"Human Blood Myeloid and Plasmacytoid Dendritic Cells Cross Activate Each Other and Synergize in Inducing NK Cell Cytotoxicity","volume":"5","author":"van Beek","year":"2016","journal-title":"Oncoimmunology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2820","article-title":"Direct Bacterial Protein PAMP Recognition by Human NK Cells Involves TLRs and Triggers Alpha-Defensin Production","volume":"104","author":"Chalifour","year":"2004","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-Gamma Production","volume":"175","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1860","article-title":"P38 MAPK Activation Controls the TLR3-Mediated Up-Regulation of Cytotoxicity and Cytokine Production in Human NK Cells","volume":"104","author":"Pisegna","year":"2004","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1619","article-title":"CpG-Containing Oligodeoxynucleotides Act Through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells","volume":"175","author":"Roda","year":"2005","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00725","article-title":"Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial","volume":"10","author":"Saxena","year":"2019","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl046","article-title":"Distinct Indirect Pathways Govern Human NK-Cell Activation by TLR-7 and TLR-8 Agonists","volume":"18","author":"Gorski","year":"2006","journal-title":"Int Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix201","article-title":"Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection","volume":"64","author":"Vibholm","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02166-16","article-title":"Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells From HIV-Infected Individuals on Suppressive Antiretroviral Therapy","volume":"91","author":"Tsai","year":"2017","journal-title":"J Virol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00235-18","article-title":"Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells Following Latency Reversal Ex Vivo","volume":"92","author":"Garrido","year":"2018","journal-title":"J Virol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005545","article-title":"A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes","volume":"12","author":"Jones","year":"2016","journal-title":"PLoS Pathog"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1946-0","article-title":"Robust and Persistent Reactivation of SIV and HIV by N-803 and Depletion of CD8(+) Cells","volume":"578","author":"McBrien","year":"2020","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01748-17","article-title":"ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment","volume":"92","author":"Ellis-Connell","year":"2018","journal-title":"J Virol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-In-Human Phase 1 Clinical Study of the IL-15 Superagonist Complex ALT-803 to Treat Relapse After Transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/s1470-2045(18)30148-7","article-title":"ALT-803, an IL-15 Superagonist, in Combination With Nivolumab in Patients With Metastatic non-Small Cell Lung Cancer: A non-Randomised, Open-Label, Phase 1b Trial","volume":"19","author":"Wrangle","year":"2018","journal-title":"Lancet Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-0945","article-title":"Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients With Advanced Solid Tumors","volume":"24","author":"Margolin","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445339","article-title":"Novel Molecular Mechanism for Generating NK-Cell Fitness and Memory","volume":"45","author":"Karo","year":"2015","journal-title":"Eur J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"a029538","DOI":"10.1101\/cshperspect.a029538","article-title":"Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination? NK Cell Memory and Immunization Strategies Against Infectious Diseases and Cancer","volume":"10","author":"Sun","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.05.008","article-title":"Natural Killer Cell Memory in Context","volume":"28","author":"Holmes","year":"2016","journal-title":"Semin Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3227","article-title":"Antigen-Specific NK Cell Memory in Rhesus Macaques","volume":"16","author":"Reeves","year":"2015","journal-title":"Nat Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/ni1332","article-title":"T Cell- and B Cell-Independent Adaptive Immunity Mediated by Natural Killer Cells","volume":"7","author":"O'Leary","year":"2006","journal-title":"Nat Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111760","article-title":"Proinflammatory Cytokine Signaling Required for the Generation of Natural Killer Cell Memory","volume":"209","author":"Sun","year":"2012","journal-title":"J Exp Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1600-065X.2010.00900.x","article-title":"Immune Memory Redefined: Characterizing the Longevity of Natural Killer Cells","volume":"236","author":"Sun","year":"2010","journal-title":"Immunol Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nature07665","article-title":"Adaptive Immune Features of Natural Killer Cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-Induced Memory-Like Natural Killer Cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00169-17","article-title":"Redefining Memory: Building the Case for Adaptive NK Cells","volume":"91","author":"Paust","year":"2017","journal-title":"J Virol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.012","article-title":"Memory Responses of Natural Killer Cells","volume":"31","author":"Geary","year":"2017","journal-title":"Semin Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a Unique CD57+NKG2Chi Natural Killer Cell Subset During Acute Human Cytomegalovirus Infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK Cells in Response to Human Cytomegalovirus-Infected Fibroblasts","volume":"107","author":"Gum\u00e1","year":"2006","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of Human Cytomegalovirus Infection on the NK Cell Receptor Repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00474","article-title":"Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection","volume":"9","author":"Peppa","year":"2018","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01143","article-title":"Natural Killer Cell Memory: Progress and Implications","volume":"8","author":"Peng","year":"2017","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the Latent Reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1792-y","article-title":"Selection and Expansion of Natural Killer Cells for NK Cell-Based Immunotherapy","volume":"65","author":"Becker","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.02.002","article-title":"Clinical Utility of Natural Killer Cells in Cancer Therapy and Transplantation","volume":"26","author":"Knorr","year":"2014","journal-title":"Semin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2016.02.006","article-title":"Natural Killer Cells Stimulated With PM21 Particles Expand and Biodistribute In Vivo: Clinical Implications for Cancer Treatment","volume":"18","author":"Oyer","year":"2016","journal-title":"Cytotherapy"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002373","article-title":"Oncolytic Parainfluenza Virus Combines With NK Cells to Mediate Killing of Infected and non-Infected Lung Cancer Cells Within 3D Spheroids: Role of Type I and Type III Interferon Signaling","volume":"9","author":"Varudkar","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14570","article-title":"Phase I Study of Cord Blood-Derived Natural Killer Cells Combined With Autologous Stem Cell Transplantation in Multiple Myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br J Haematol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1203\/01.Pdr.0000156501.55431.20","article-title":"Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections","volume":"57","author":"Dalle","year":"2005","journal-title":"Pediatr Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/14653240802301872","article-title":"Infusion of the Allogeneic Cell Line NK-92 in Patients With Advanced Renal Cell Cancer or Melanoma: A Phase I Trial","volume":"10","author":"Arai","year":"2008","journal-title":"Cytotherapy"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00533","article-title":"Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-The-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/cells9061382","article-title":"Anti-PSMA CAR-Engineered NK-92 Cells: An Off-The-Shelf Cell Therapy for Prostate Cancer","volume":"9","author":"Montagner","year":"2020","journal-title":"Cells"},{"key":"B148","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/blood.2019000621","article-title":"Pluripotent Stem Cell-Derived NK Cells With High-Affinity Noncleavable CD16a Mediate Improved Antitumor Activity","volume":"135","author":"Zhu","year":"2020","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults With B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-Up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1060028020944233","article-title":"Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-Cell Therapy in Relapsed and Refractory Large B-Cell Lymphoma","volume":"55","author":"Halford","year":"2021","journal-title":"Ann Pharmacother"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated With Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B154","doi-asserted-by":"publisher","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrclinonc.2018.20","article-title":"Toxicity Management After Chimeric Antigen Receptor T Cell Therapy: One Size Does Not Fit 'ALL'","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1611","article-title":"Expression of Chimeric Receptor CD4\u03b6 by Natural Killer Cells Derived From Human Pluripotent Stem Cells Improves In Vitro Activity But Does Not Enhance Suppression of HIV Infection In Vivo","volume":"32","author":"Ni","year":"2014","journal-title":"Stem Cells"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.102","article-title":"HIV-Specific Immunity Derived From Chimeric Antigen Receptor-Engineered Stem Cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol Ther"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00537","article-title":"A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1 Gp160","volume":"15","author":"Lim","year":"2020","journal-title":"ACS Chem Biol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4434","article-title":"Can NK Cells Purge HIV Sanctuaries","volume":"23","author":"Bunders","year":"2017","journal-title":"Nat Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000002743","article-title":"TRIGGERED: Could Refocused Cell Signaling be Key to Natural Killer Cell-Based HIV Immunotherapeutics","volume":"35","author":"Sugawara","year":"2021","journal-title":"Aids"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.842746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T02:16:05Z","timestamp":1674958565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.842746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2022.842746"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.842746","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"article-number":"842746"}}